×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.14.
1 week ago
Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results
Simply Wall Street
A week ago, MaxCyte, Inc. ( LON:MXCT ) came out with a strong set of first-quarter numbers that could potentially lead...
6 days ago
FY2024 EPS Estimates for MaxCyte, Inc. Boosted by Analyst (NASDAQ:MXCT)
MarketBeat
MaxCyte, Inc. (NASDAQ:MXCT - Free Report) - William Blair lifted their FY2024 earnings estimates for MaxCyte in a research report issued to...
2 days ago
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
Insider Monkey
Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call.
3 days ago
Earnings call: MaxCyte sees steady growth and strategic partnerships in Q1 2024
Investing.com
MaxCyte, Inc. (MXCT) reported a solid start to the fiscal year 2024, with total revenue reaching $11.3 million in the first quarter.
4 days ago
MaxCyte Inc Shares Corporate Update Presentation Online - TipRanks.com
Tipranks
MaxCyte Inc (MXCT) just unveiled an announcement. On May 7, 2024, the Company made its updated corporate presentation available on its...
1 week ago
MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member
News-Medical
MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery,...
5 months ago
MaxCyte Inc (MXCT) Reports Mixed Financial Results for Q4 and Full Year 2023
Yahoo Finance
MaxCyte Inc (MXCT) Reports Mixed Financial Results for Q4 and Full Year 2023 · Total Revenue: Q4 saw a 26% increase year-over-year, but full...
2 months ago
MaxCyte reports strong first quarter
Sharecast.com
MaxCyte reported total first-quarter revenue of $11.3m in an update on Wednesday, making for a 32% increase compared to the same period in...
1 week ago
Roubaix Capital LLC Invests $1.82 Million in MaxCyte, Inc. (NASDAQ:MXCT)
MarketBeat
Roubaix Capital LLC purchased a new position in shares of MaxCyte, Inc. (NASDAQ:MXCT - Free Report) in the 4th quarter, according to the...
3 days ago